Participants in the medical devices market are currently facing the challenge of offering affordable products to customers while increasing investment in research and development (R&D).
New analysis from Frost & Sullivan, (medicaldevices.frost.com), World Medical Devices – Investment Analysis and Growth Opportunities, reveals that revenues in the U.S. market totaled $63.76 billion in 2004 and projects to reach $139.75 billion in 2011.
If you are interested in a virtual brochure, which provides manufacturers, end-users, and other industry participants an overview of the latest analysis of the World Medical Devices – Investment Analysis and Growth Opportunities, please send an e-mail to Melina Trevino, Corporate Communications, at melina.trevino[...]frost.com, with your full name, company name, title, telephone number, fax number, and e-mail address. Upon receipt of the above information, an overview will be sent to you by e-mail.
“The economic health of the participants in the market largely depends on their ability to continuously innovate, thus leading to higher R&D expenditures on new product development,” says Frost & Sullivan Financial Analyst Sheetal S Rajani.
In addition to keeping abreast with the latest technologies, medical device manufacturers are also being compelled to cut costs as a result of cost containment pressures from group purchasing organizations (GPOs).
“Approximately 96.0 to 98.0 percent of the hospitals in the United States include GPOs in their purchasing functions and strongly influence the pricing strategies of medical device companies,” explains Rajani.
Although large-cap companies are able to meet these price pressures and consistently invest a larger portion of their sales in R&D, small and medium-cap companies are finding it increasingly difficult to pick up the pace and invest higher amounts in R&D.
In fact, the top ten companies in the medical devices market accounted for 70.5 percent of the total R&D spending in 2003. Moreover, in 2004, large-cap companies invested around 8.0 percent of their revenues in R&D, while small and medium-cap companies invested only 4.0 percent, representing half the ratio demonstrated by their large-cap counterparts.
In a bid to increase R&D expenditures while keeping costs at minimum, manufacturers of medical devices are attempting to lower the selling, general, and administrative (SGA) expenses.
“SGA expenses constitute almost a third of revenues from sales for large-cap companies and a quarter for small and medium-cap companies,” observes Rajani.
Despite the cost containment challenges, manufacturers of medical devices are expected to find new revenue generation opportunities outside the United States, specifically in under-penetrated countries, such as India and China, with large populations and developing healthcare systems.
The medical devices market is also poised for further growth, largely due to the rising popularity of cardiovascular and orthopedic devices, disposable surgical supplies, and robot-assisted and image-guided surgeries.
World Medical Devices – Investment Analysis and Growth Opportunities, part of the Financial Benchmarking & Analysis in the Medical Devices Industry subscription, provides a comprehensive financial analysis of leading medical devices companies and supports the investment and financial analysis needs of decision makers in the marketplace. It segments the market into cardiovascular devices, orthopedic devices, wound care and management, surgical instrumentation, neurology equipment, infusion systems, opthamology equipment, hearing aids, respiratory and anesthesia, and endoscopy systems. The markets for disinfection and sterilization products, durable medical equipment, dialysis equipment, biomaterials and hemostats, disposable surgical supplies, fitness equipment, cosmetic and aesthetic equipments, and robot assisted & image guided surgery equipment are also covered. Analyst interviews are available to the press.
Frost & Sullivan's Business and Financial Services group serves clients around the world in all aspects of financial analysis, market research and monitoring, due diligence, idea generation, opportunity analysis, investment valuation, and other proprietary research.
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.
World Medical Devices – Investment Analysis and Growth Opportunities F451
Corporate Communications – Europe
P: +44 (0) 20 7915 7856
F: +44 (0) 20 7730 3343
Radhika Menon Theodore
Corporate Communications – Asia Pacific
P: +91 44 24314263 Ext: 312
Corporate Communications – India
P: +91 22 2832 4705 Ext: 131
Keywords in this release: medical devices, investment, opportunity, research and development, R&D, Group Purchasing Organizations, GPOs, selling general and administrative expenses, SGA expenses, cardiovascular devices, orthopedic devices, wound care and management, surgical instrumentation, neurology equipment, infusion systems, opthamology equipment, hearing aids, respiratory and anesthesia, endoscopy systems, disinfection and sterilization products, durable medical equipment, dialysis equipment, biomaterials and hemostats , disposable surgical supplies, fitness equipment, cosmetic and aesthetic equipments, robot-assisted and image-guided surgeries, research, information, market, trends, technology, service, forecast, market share